Susan Bergin, General Counsel

Solicitor, dual-qualified in Medicinal Chemistry & Law (LLM), passionate about longevity, legalisation of plant medicines & human rights.

Currently serving as General Counsel for Juvenescence - a biotech longevity company working to change the way we age by developing therapeutics that help people live longer, healthier lives.

Previously advised leading pharmaceutical, biotechnology and medical device companies in regulatory and IP matters that require technical knowledge of small molecule and biologic drug discovery, antibody technologies, pharmaceutical formulations, dosage regimens, medical devices, supplements and vaccines.

On the corporate side, worked on numerous cross-border pharma and technology transactions supporting clients with complex due diligence, licensing & commercial contracts.

Pro-bono work supporting charities and start-ups on commercial, IP, regulatory & privacy issues.

Completed an internship with AbbVie in the United States, was selected to attend the World Intellectual Property Organisation (WIPO) Summer School in Geneva, and worked with the UN International Labour Organisation on IP issues in the Nepal Himalaya.

Executive Partners